Logo image of SBRA

SABRA HEALTH CARE REIT INC (SBRA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SBRA - US78573L1061 - REIT

18.73 USD
+0.18 (+0.97%)
Last: 11/21/2025, 8:00:02 PM
18.73 USD
0 (0%)
After Hours: 11/21/2025, 8:00:02 PM
Fundamental Rating

6

Overall SBRA gets a fundamental rating of 6 out of 10. We evaluated SBRA against 128 industry peers in the Diversified REITs industry. Both the profitability and the financial health of SBRA get a neutral evaluation. Nothing too spectacular is happening here. SBRA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make SBRA suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SBRA was profitable.
In the past year SBRA had a positive cash flow from operations.
In multiple years SBRA reported negative net income over the last 5 years.
Each year in the past 5 years SBRA had a positive operating cash flow.
SBRA Yearly Net Income VS EBIT VS OCF VS FCFSBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

SBRA has a Return On Assets of 3.15%. This is in the better half of the industry: SBRA outperforms 78.13% of its industry peers.
Looking at the Return On Equity, with a value of 6.20%, SBRA is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
SBRA has a Return On Invested Capital of 3.87%. This is in the better half of the industry: SBRA outperforms 74.22% of its industry peers.
SBRA had an Average Return On Invested Capital over the past 3 years of 3.52%. This is in line with the industry average of 3.04%.
The 3 year average ROIC (3.52%) for SBRA is below the current ROIC(3.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.15%
ROE 6.2%
ROIC 3.87%
ROA(3y)0.43%
ROA(5y)0.34%
ROE(3y)0.86%
ROE(5y)0.66%
ROIC(3y)3.52%
ROIC(5y)3.4%
SBRA Yearly ROA, ROE, ROICSBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

With a decent Profit Margin value of 23.50%, SBRA is doing good in the industry, outperforming 75.00% of the companies in the same industry.
SBRA's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 35.78%, SBRA is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
SBRA's Operating Margin has declined in the last couple of years.
The Gross Margin of SBRA (68.38%) is comparable to the rest of the industry.
SBRA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 35.78%
PM (TTM) 23.5%
GM 68.38%
OM growth 3Y-0.95%
OM growth 5Y-4.46%
PM growth 3YN/A
PM growth 5Y9.21%
GM growth 3Y-4.03%
GM growth 5Y-3.89%
SBRA Yearly Profit, Operating, Gross MarginsSBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SBRA is destroying value.
SBRA has more shares outstanding than it did 1 year ago.
SBRA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SBRA is higher compared to a year ago.
SBRA Yearly Shares OutstandingSBRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SBRA Yearly Total Debt VS Total AssetsSBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that SBRA is in the distress zone and has some risk of bankruptcy.
SBRA has a better Altman-Z score (0.81) than 67.97% of its industry peers.
The Debt to FCF ratio of SBRA is 168.41, which is on the high side as it means it would take SBRA, 168.41 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 168.41, SBRA is doing good in the industry, outperforming 60.94% of the companies in the same industry.
SBRA has a Debt/Equity ratio of 0.92. This is a neutral value indicating SBRA is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.92, SBRA is doing good in the industry, outperforming 66.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 168.41
Altman-Z 0.81
ROIC/WACC0.56
WACC6.86%
SBRA Yearly LT Debt VS Equity VS FCFSBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

SBRA has a Current Ratio of 2.48. This indicates that SBRA is financially healthy and has no problem in meeting its short term obligations.
SBRA has a Current ratio of 2.48. This is amongst the best in the industry. SBRA outperforms 86.72% of its industry peers.
A Quick Ratio of 2.48 indicates that SBRA has no problem at all paying its short term obligations.
SBRA has a better Quick ratio (2.48) than 86.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 2.48
SBRA Yearly Current Assets VS Current LiabilitesSBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 75.61% over the past year.
SBRA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.28% yearly.
SBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.88%.
The Revenue has been growing slightly by 3.41% on average over the past years.
EPS 1Y (TTM)75.61%
EPS 3YN/A
EPS 5Y9.28%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)8.88%
Revenue growth 3Y7.31%
Revenue growth 5Y3.41%
Sales Q2Q%6.76%

3.2 Future

The Earnings Per Share is expected to grow by 16.42% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.62% on average over the next years. This is quite good.
EPS Next Y47.55%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue Next Year7.85%
Revenue Next 2Y8.44%
Revenue Next 3Y9.83%
Revenue Next 5Y9.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SBRA Yearly Revenue VS EstimatesSBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SBRA Yearly EPS VS EstimatesSBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

SBRA is valuated quite expensively with a Price/Earnings ratio of 26.01.
Compared to the rest of the industry, the Price/Earnings ratio of SBRA indicates a somewhat cheap valuation: SBRA is cheaper than 73.44% of the companies listed in the same industry.
SBRA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.45.
With a Price/Forward Earnings ratio of 23.34, SBRA is valued on the expensive side.
Based on the Price/Forward Earnings ratio, SBRA is valued cheaply inside the industry as 86.72% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SBRA to the average of the S&P500 Index (34.46), we can say SBRA is valued slightly cheaper.
Industry RankSector Rank
PE 26.01
Fwd PE 23.34
SBRA Price Earnings VS Forward Price EarningsSBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBRA is on the same level as its industry peers.
SBRA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 291.91
EV/EBITDA 15.39
SBRA Per share dataSBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

SBRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SBRA may justify a higher PE ratio.
A more expensive valuation may be justified as SBRA's earnings are expected to grow with 16.42% in the coming years.
PEG (NY)0.55
PEG (5Y)2.8
EPS Next 2Y23.04%
EPS Next 3Y16.42%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.42%, SBRA is a good candidate for dividend investing.
SBRA's Dividend Yield is a higher than the industry average which is at 6.50.
SBRA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 6.42%

5.2 History

The dividend of SBRA decreases each year by -7.34%.
SBRA has been paying a dividend for at least 10 years, so it has a reliable track record.
SBRA has decreased its dividend recently.
Dividend Growth(5Y)-7.34%
Div Incr Years0
Div Non Decr Years1
SBRA Yearly Dividends per shareSBRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

163.17% of the earnings are spent on dividend by SBRA. This is not a sustainable payout ratio.
DP163.17%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
SBRA Yearly Income VS Free CF VS DividendSBRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
SBRA Dividend Payout.SBRA Dividend Payout, showing the Payout Ratio.SBRA Dividend Payout.PayoutRetained Earnings

SABRA HEALTH CARE REIT INC

NASDAQ:SBRA (11/21/2025, 8:00:02 PM)

After market: 18.73 0 (0%)

18.73

+0.18 (+0.97%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners100.95%
Inst Owner Change1.83%
Ins Owners1.03%
Ins Owner Change3.63%
Market Cap4.49B
Revenue(TTM)745.08M
Net Income(TTM)175.08M
Analysts76
Price Target20.91 (11.64%)
Short Float %7.98%
Short Ratio6.48
Dividend
Industry RankSector Rank
Dividend Yield 6.42%
Yearly Dividend1.2
Dividend Growth(5Y)-7.34%
DP163.17%
Div Incr Years0
Div Non Decr Years1
Ex-Date11-17 2025-11-17 (0.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.24%
Min EPS beat(2)-51.75%
Max EPS beat(2)51.26%
EPS beat(4)2
Avg EPS beat(4)2.43%
Min EPS beat(4)-51.75%
Max EPS beat(4)51.26%
EPS beat(8)2
Avg EPS beat(8)-14.25%
EPS beat(12)2
Avg EPS beat(12)-67%
EPS beat(16)3
Avg EPS beat(16)-79.33%
Revenue beat(2)1
Avg Revenue beat(2)1.26%
Min Revenue beat(2)-0.25%
Max Revenue beat(2)2.77%
Revenue beat(4)3
Avg Revenue beat(4)0.96%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)2.77%
Revenue beat(8)7
Avg Revenue beat(8)1.58%
Revenue beat(12)8
Avg Revenue beat(12)1.29%
Revenue beat(16)9
Avg Revenue beat(16)-0.42%
PT rev (1m)-0.22%
PT rev (3m)3.44%
EPS NQ rev (1m)0.89%
EPS NQ rev (3m)0.89%
EPS NY rev (1m)3.14%
EPS NY rev (3m)8.75%
Revenue NQ rev (1m)0.87%
Revenue NQ rev (3m)2.55%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 26.01
Fwd PE 23.34
P/S 6.03
P/FCF 291.91
P/OCF 13.16
P/B 1.59
P/tB 1.62
EV/EBITDA 15.39
EPS(TTM)0.72
EY3.84%
EPS(NY)0.8
Fwd EY4.28%
FCF(TTM)0.06
FCFY0.34%
OCF(TTM)1.42
OCFY7.6%
SpS3.11
BVpS11.78
TBVpS11.53
PEG (NY)0.55
PEG (5Y)2.8
Graham Number13.81
Profitability
Industry RankSector Rank
ROA 3.15%
ROE 6.2%
ROCE 4.9%
ROIC 3.87%
ROICexc 4.02%
ROICexgc 4.07%
OM 35.78%
PM (TTM) 23.5%
GM 68.38%
FCFM 2.07%
ROA(3y)0.43%
ROA(5y)0.34%
ROE(3y)0.86%
ROE(5y)0.66%
ROIC(3y)3.52%
ROIC(5y)3.4%
ROICexc(3y)3.55%
ROICexc(5y)3.44%
ROICexgc(3y)3.57%
ROICexgc(5y)3.46%
ROCE(3y)4.45%
ROCE(5y)4.3%
ROICexgc growth 3Y10.05%
ROICexgc growth 5Y1.42%
ROICexc growth 3Y10.2%
ROICexc growth 5Y1.69%
OM growth 3Y-0.95%
OM growth 5Y-4.46%
PM growth 3YN/A
PM growth 5Y9.21%
GM growth 3Y-4.03%
GM growth 5Y-3.89%
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 168.41
Debt/EBITDA 5.83
Cap/Depr 183.12%
Cap/Sales 43.72%
Interest Coverage 2.51
Cash Conversion 76.75%
Profit Quality 8.79%
Current Ratio 2.48
Quick Ratio 2.48
Altman-Z 0.81
F-Score6
WACC6.86%
ROIC/WACC0.56
Cap/Depr(3y)57.48%
Cap/Depr(5y)56.11%
Cap/Sales(3y)15.43%
Cap/Sales(5y)15.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.61%
EPS 3YN/A
EPS 5Y9.28%
EPS Q2Q%-30.77%
EPS Next Y47.55%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue 1Y (TTM)8.88%
Revenue growth 3Y7.31%
Revenue growth 5Y3.41%
Sales Q2Q%6.76%
Revenue Next Year7.85%
Revenue Next 2Y8.44%
Revenue Next 3Y9.83%
Revenue Next 5Y9.62%
EBIT growth 1Y9.23%
EBIT growth 3Y6.29%
EBIT growth 5Y-1.21%
EBIT Next Year83.79%
EBIT Next 3Y27.39%
EBIT Next 5Y19.52%
FCF growth 1Y-93.63%
FCF growth 3Y-12.17%
FCF growth 5Y-11.54%
OCF growth 1Y17.87%
OCF growth 3Y-4.49%
OCF growth 5Y-3.57%

SABRA HEALTH CARE REIT INC / SBRA FAQ

What is the ChartMill fundamental rating of SABRA HEALTH CARE REIT INC (SBRA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SBRA.


What is the valuation status for SBRA stock?

ChartMill assigns a valuation rating of 5 / 10 to SABRA HEALTH CARE REIT INC (SBRA). This can be considered as Fairly Valued.


How profitable is SABRA HEALTH CARE REIT INC (SBRA) stock?

SABRA HEALTH CARE REIT INC (SBRA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SBRA stock?

The Price/Earnings (PE) ratio for SABRA HEALTH CARE REIT INC (SBRA) is 26.01 and the Price/Book (PB) ratio is 1.59.


Can you provide the financial health for SBRA stock?

The financial health rating of SABRA HEALTH CARE REIT INC (SBRA) is 5 / 10.